Results 191 to 200 of about 58,205 (308)

Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance [PDF]

open access: gold, 2023
Stephen V. Carney   +25 more
openalex   +1 more source

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial

open access: yesHematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT Primary myelofibrosis (PMF) is a chronic myeloproliferative neoplasm characterized by the activation of the JAK‐STAT pathway. Previous evidence showed that metformin might be a possible therapeutic option for treating JAK2‐mediated myeloproliferative neoplasms.
Paula de Melo Campos   +11 more
wiley   +1 more source

Diagnostic and prognostic value of IDH1 mutation in gliomas

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2012
Objective To discuss the significance of IDH1 mutation for diagnosis and prognosis of gliomas through detecting of IDH1 mutation in supratentorial glioma cells.
Yan⁃wu YANG   +6 more
doaj  

Data from Loss of FBXW7 Correlates with Increased IDH1 Expression in Glioma and Enhances IDH1-Mutant Cancer Cell Sensitivity to Radiation

open access: gold, 2023
Zhuo Yang   +12 more
openalex   +1 more source

Supplementary Table S2 from Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance [PDF]

open access: gold, 2023
Stephen V. Carney   +25 more
openalex   +1 more source

High‐Throughput 3D Glioblastoma Model in Glycosaminoglycan Hydrogels for Personalized Therapeutic Screening

open access: yesMacromolecular Bioscience, Volume 26, Issue 1, January 2026.
Kaur–Trautmann et al. present a high‐throughput, chemically defined 3D glioblastoma model based on glycosaminoglycan hydrogels that allow orthogonal control of stiffness, adhesion, and degradability while standardizing soluble‐factor presentation. The platform supports automated imaging and transcriptomic profiling, enabling patient‐specific drug ...
Rajvinder Kaur Trautmann   +9 more
wiley   +1 more source

Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia. [PDF]

open access: yesBlood Cancer J
Steinhäuser S   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy